CLASSIFIEDS


DERMALEX Skincare brand Dermalex is making its TV campaign


debut as parent company, Perrigo, makes its largest marketing investment yet on the brand. The TV campaign will be on screens for six weeks from 23rd


October to 20th November. As well as the


adverts, Dermalex is partnering with key infl uencers including independent pharmacy consultant Dr Christine Clark, bloggers and vloggers. A Facebook page has also been launched where customers can fi nd expert help and advice.


NIQUITIN LAUNCHES EXTRA FRESH MINT GUM


Perrigo, a leading provider of medicines and healthcare products, is launching NiQuitin Extra Fresh Mint gum with a full 360 marketing campaign kicking off in line with Public Health England’s Stoptober initiative. The launch consists of a £2.2 million media campaign with mass sampling and pharmacy training. New Extra Fresh Mint gum combines 3 mint fl avours as well as 50-60 layers of coating to deliver unbeatable fl avour* and help smokers quit the habit.


*216 person sensory study comparing 2mg nicotine gums.


EPISTATUS® 10 MG OROMUCOSAL SOLUTION MIDAZOLAM – NOW AVAILABLE TO PRESCRIBE


8th September 2017: Special Products Ltd is pleased to announce that Epistatus® 10 mg Oromucosal Solution, Midazolam, is now available to prescribe. The NHS price for a single 10mg in 1mL prefi lled syringe is £45.76.


Epistatus® is licensed for use in the treatment of prolonged, acute convulsive seizures in children and adolescents aged 10 to less than 18 years, who have been diagnosed with epilepsy1. Buccal midazolam is recommended by NICE2 for the management of prolonged acute convulsive seizures, and is preferred by most patients and carers compared to the administration of rectal diazepam 3,4.


Epistatus is presented “ready-to-use” in a novel, pre-fi lled, single-dose syringe, to provide carers with the confi dence that they are administering the correct dose1,5. The pre-fi lled syringe is contained within a specially-designed, secure and tamper-evident protective packaging.


Dr Rohit Shankar FRCPsych, Consultant in Adult Developmental Neuropsychiatry – CFT and Hon. Associate Clinical Professor - Exeter Medical School commented: “The importance of having an alternate licensed preparation for use in the treatment of prolonged, acute convulsive seizures, especially in a different mode of delivery is an asset to both clinicians and patients".


In response to market research and insights, Special Products Ltd has invested heavily in the development of this new bespoke syringe, which is designed to allow simple administration of the dose into the buccal cavity5.


Community Pharmacists can obtain Epistatus® 10mg/1mL pre-fi lled syringes exclusively via Alliance Healthcare.


Hospitals can order Epistatus® 10mg/1mL pre-fi lled syringes directly from Special Products Limited www.specialproducts.biz


For further information on Epistatus 10 mg oromucosal midazolam pre-fi lled syringes, please visit www.epistatus.co.uk


Struggling with a dependency issue?


WE CAN HELP Health Support Programme


Confidential specialist advice on a range of dependency issues including alcohol, drugs, gambling, and eating disorders


RELIEF PHARMACY MANAGER


Temporary position supporting our Tayside & Fife Branches


To apply please send a CV to karen.gordon@wdavidsons.co.uk


or for further information please contact


Karen Gordon, Superintendent Pharmacist & Operations Director on 01250 872308


Pharmacist Support – the profession’s independent charity Call Health Support helpline: 0808 168 5132 Call general enquiries: 0808 168 2233 Visit: www.pharmacistsupport.org Email: info@pharmacistsupport.org


Pharmacist Support is a charitable company limited by guarantee registered in England & Wales, company no 9237609 & charity no 1158974


Courage


Confidence


Recovery


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48